Skip to content

Clinical trials

Obesity trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Obesity Country / region: France Clear all

461 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20013
20022
20032
20043
200510
20067
20078
200813
200911
201018
201121
201216
201318
201419
201528
201622
201719
201830
201926
202022
202127
202225
202324
202421
202537
202627

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed254
Recruiting71
Unknown status61
Terminated34
Not yet recruiting23
Active, not recruiting15
Withdrawn2
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Assistance Publique - Hôpitaux de Paris51
University Hospital, Clermont-Ferrand41
Hospices Civils de Lyon32
University Hospital, Lille22
University Hospital, Montpellier22
Novo Nordisk A/S19
University Hospital, Toulouse18
Centre Hospitalier Universitaire de Nice11
University Hospital, Grenoble11
University Hospital, Bordeaux10

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Obesity461
Overweight70
Diabetes Mellitus, Type 233
Obesity, Morbid24
Diabetes Mellitus23
Pediatric Obesity16
Sleep Apnea, Obstructive15
Metabolic Syndrome14
Weight Loss14
Insulin Resistance11

Trials

Showing 1 to 25 of 461. Each trial links to its page on Pharma Observatory.

361 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.